Single-cell transcriptomic profiling of bronchial lymph nodes reveals mechanisms of PRRSV escape from host adaptive immunity - Scorecard - MDSpire

Single-cell transcriptomic profiling of bronchial lymph nodes reveals mechanisms of PRRSV escape from host adaptive immunity

  • By

  • Shu-yuan Guo

  • Xuan Wang

  • Jiaying Zhu

  • Chang Liu

  • Hao Zhou

  • Yaqi Chen

  • Yu Bai

  • Haoran Liu

  • Wen-hai Feng

  • July 15, 2026

Share

Clinical Scorecard: Single-cell RNA sequencing of bronchial lymph nodes uncovers strategies used by PRRSV to evade host adaptive immune responses

At a Glance

CategoryDetail
ConditionPorcine reproductive and respiratory syndrome (PRRS)
Key MechanismsImpaired adaptive immune responses, including delayed neutralizing antibody development and defective T-cell responses.
Target PopulationPiglets infected with highly pathogenic PRRSV (HP-PRRSV).
Care SettingVeterinary clinical research.

Key Highlights

  • HP-PRRSV infection reduces multiple T-cell subsets while increasing B cells in bronchial lymph nodes.
  • Infection disrupts T-cell egress, leading to accumulation of cytotoxic T lymphocytes.
  • Impaired crosstalk between T follicular helper cells and germinal center B cells may suppress neutralizing antibody production.
  • Identification of a novel RAG1+ CD4+CD8+ double-positive T-cell subset associated with PRRSV.
  • Study provides insights into mechanisms of PRRSV-induced adaptive immunosuppression.

Guideline-Based Recommendations

Diagnosis

  • Single-cell RNA sequencing can be utilized to analyze immune responses in PRRSV infection.

Management

  • Further research is needed to develop effective vaccines and antiviral strategies against PRRSV.

Monitoring & Follow-up

  • Monitor T-cell and B-cell responses in infected populations to assess immune status.

Risks

  • Delayed neutralizing antibody production may lead to prolonged viral replication and persistence.

Patient & Prescribing Data

Piglets infected with HP-PRRSV.

Currently, no broad-spectrum, highly effective, and safe vaccine is available for PRRSV.

Clinical Best Practices

  • Utilize single-cell transcriptomic analysis to understand immune landscape changes in PRRSV infection.
  • Focus on enhancing T-cell and B-cell interactions to improve vaccine efficacy.

Related Resources & Content

Original Source(s)

Related Content